世界の神経遮断剤市場 2019年

【英語タイトル】Global Neuroleptic Market Professional Survey Report 2019

QYResearchが出版した調査資料(DATA909X11953)・商品コード:DATA909X11953
・発行会社(調査会社):QYResearch
・発行日:2019年11月20日(※2024年版があります。お問い合わせください)
・ページ数:107
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥518,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,250 ⇒換算¥777,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥1,036,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートは、神経遮断剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ドロペリドール、ミダゾラムに、用途別には、医療、科学研究、その他にセグメント区分し、神経遮断剤の世界市場を分析しました。


・エグゼクティブ・サマリー
・神経遮断剤の世界市場概要
・神経遮断剤の製造コスト構成分析
・神経遮断剤の開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・神経遮断剤の地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・神経遮断剤のセグメント分析(種類別)
(ドロペリドール、ミダゾラム)
・神経遮断剤のセグメント分析(用途別)
(医療、科学研究、その他)
・神経遮断剤の主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Johnson & Johnso、Pfizer、Eli Lilly、Bristol-Myers Squibb、GlaxoSmithKline、)
・神経遮断剤の市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

The global Neuroleptic market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Neuroleptic volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neuroleptic market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Neuroleptic in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Neuroleptic manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Johnson & Johnso
Pfizer
Eli Lilly
Bristol-Myers Squibb
GlaxoSmithKline

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Droperidol
Midazolam

Segment by Application
Medical Care
Scientific Research
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Neuroleptic
1.1 Definition of Neuroleptic
1.2 Neuroleptic Segment by Type
1.2.1 Global Neuroleptic Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Droperidol
1.2.3 Midazolam
1.3 Neuroleptic Segment by Applications
1.3.1 Global Neuroleptic Consumption Comparison by Applications (2014-2025)
1.3.2 Medical Care
1.3.3 Scientific Research
1.3.4 Others
1.4 Global Neuroleptic Overall Market
1.4.1 Global Neuroleptic Revenue (2014-2025)
1.4.2 Global Neuroleptic Production (2014-2025)
1.4.3 North America Neuroleptic Status and Prospect (2014-2025)
1.4.4 Europe Neuroleptic Status and Prospect (2014-2025)
1.4.5 China Neuroleptic Status and Prospect (2014-2025)
1.4.6 Japan Neuroleptic Status and Prospect (2014-2025)
1.4.7 Southeast Asia Neuroleptic Status and Prospect (2014-2025)
1.4.8 India Neuroleptic Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Neuroleptic
2.3 Manufacturing Process Analysis of Neuroleptic
2.4 Industry Chain Structure of Neuroleptic

3 Development and Manufacturing Plants Analysis of Neuroleptic
3.1 Capacity and Commercial Production Date
3.2 Global Neuroleptic Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Neuroleptic
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Neuroleptic Production and Capacity Analysis
4.2 Neuroleptic Revenue Analysis
4.3 Neuroleptic Price Analysis
4.4 Market Concentration Degree

5 Neuroleptic Regional Market Analysis
5.1 Neuroleptic Production by Regions
5.1.1 Global Neuroleptic Production by Regions
5.1.2 Global Neuroleptic Revenue by Regions
5.2 Neuroleptic Consumption by Regions
5.3 North America Neuroleptic Market Analysis
5.3.1 North America Neuroleptic Production
5.3.2 North America Neuroleptic Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Neuroleptic Import and Export
5.4 Europe Neuroleptic Market Analysis
5.4.1 Europe Neuroleptic Production
5.4.2 Europe Neuroleptic Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Neuroleptic Import and Export
5.5 China Neuroleptic Market Analysis
5.5.1 China Neuroleptic Production
5.5.2 China Neuroleptic Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Neuroleptic Import and Export
5.6 Japan Neuroleptic Market Analysis
5.6.1 Japan Neuroleptic Production
5.6.2 Japan Neuroleptic Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Neuroleptic Import and Export
5.7 Southeast Asia Neuroleptic Market Analysis
5.7.1 Southeast Asia Neuroleptic Production
5.7.2 Southeast Asia Neuroleptic Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Neuroleptic Import and Export
5.8 India Neuroleptic Market Analysis
5.8.1 India Neuroleptic Production
5.8.2 India Neuroleptic Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Neuroleptic Import and Export

6 Neuroleptic Segment Market Analysis (by Type)
6.1 Global Neuroleptic Production by Type
6.2 Global Neuroleptic Revenue by Type
6.3 Neuroleptic Price by Type

7 Neuroleptic Segment Market Analysis (by Application)
7.1 Global Neuroleptic Consumption by Application
7.2 Global Neuroleptic Consumption Market Share by Application (2014-2019)

8 Neuroleptic Major Manufacturers Analysis
8.1 Johnson & Johnso
8.1.1 Johnson & Johnso Neuroleptic Production Sites and Area Served
8.1.2 Johnson & Johnso Product Introduction, Application and Specification
8.1.3 Johnson & Johnso Neuroleptic Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Pfizer
8.2.1 Pfizer Neuroleptic Production Sites and Area Served
8.2.2 Pfizer Product Introduction, Application and Specification
8.2.3 Pfizer Neuroleptic Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Eli Lilly
8.3.1 Eli Lilly Neuroleptic Production Sites and Area Served
8.3.2 Eli Lilly Product Introduction, Application and Specification
8.3.3 Eli Lilly Neuroleptic Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Bristol-Myers Squibb
8.4.1 Bristol-Myers Squibb Neuroleptic Production Sites and Area Served
8.4.2 Bristol-Myers Squibb Product Introduction, Application and Specification
8.4.3 Bristol-Myers Squibb Neuroleptic Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 GlaxoSmithKline
8.5.1 GlaxoSmithKline Neuroleptic Production Sites and Area Served
8.5.2 GlaxoSmithKline Product Introduction, Application and Specification
8.5.3 GlaxoSmithKline Neuroleptic Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served

9 Development Trend of Analysis of Neuroleptic Market
9.1 Global Neuroleptic Market Trend Analysis
9.1.1 Global Neuroleptic Market Size (Volume and Value) Forecast 2019-2025
9.2 Neuroleptic Regional Market Trend
9.2.1 North America Neuroleptic Forecast 2019-2025
9.2.2 Europe Neuroleptic Forecast 2019-2025
9.2.3 China Neuroleptic Forecast 2019-2025
9.2.4 Japan Neuroleptic Forecast 2019-2025
9.2.5 Southeast Asia Neuroleptic Forecast 2019-2025
9.2.6 India Neuroleptic Forecast 2019-2025
9.3 Neuroleptic Market Trend (Product Type)
9.4 Neuroleptic Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Neuroleptic Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Neuroleptic
Table Global Neuroleptic Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Neuroleptic Production Market Share by Types in 2018
Figure Droperidol Product Picture
Figure Midazolam Product Picture
Table Global Neuroleptic Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Neuroleptic Consumption Market Share by Applications in 2018
Figure Medical Care
Figure Scientific Research
Figure Others
Figure Global Neuroleptic Revenue (Million USD) (2014-2025)
Figure Global Neuroleptic Production (K Pcs) (2014-2025)
Figure North America Neuroleptic Market Size (Million USD) (2014-2025)
Figure Europe Neuroleptic Market Size (Million USD) (2014-2025)
Figure China Neuroleptic Market Size (Million USD) (2014-2025)
Figure Japan Neuroleptic Market Size (Million USD) (2014-2025)
Figure Southeast Asia Neuroleptic Market Size (Million USD) (2014-2025)
Figure India Neuroleptic Market Size (Million USD) (2014-2025)
Table Neuroleptic Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Neuroleptic in 2018
Figure Manufacturing Process Analysis of Neuroleptic
Figure Industry Chain Structure of Neuroleptic
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Neuroleptic Manufacturing Plants Distribution
Table Neuroleptic Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Neuroleptic Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Neuroleptic Production (K Pcs) of Major Manufacturers (2014-2019)
Table Neuroleptic Production Market Share of Major Manufacturers (2014-2019)
Figure Neuroleptic Production Share by Manufacturers in 2018
Table Neuroleptic Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Neuroleptic Revenue Market Share of Major Manufacturers (2014-2019)
Figure Neuroleptic Revenue Share by Manufacturers in 2018
Table Neuroleptic Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Neuroleptic Production by Regions 2014-2019 (K Pcs)
Table Global Neuroleptic Production Market Share by Regions 2014-2019
Figure Global Neuroleptic Production Market Share by Regions in 2018
Table Global Neuroleptic Revenue by Regions 2014-2019 (Million USD)
Table Global Neuroleptic Revenue Market Share by Regions 2014-2019
Figure Global Neuroleptic Revenue Market Share by Regions in 2018
Table Global Neuroleptic Consumption by Regions 2014-2019 (K Pcs)
Table Global Neuroleptic Consumption Market Share by Regions 2014-2019
Figure North America Neuroleptic Production Growth Rate 2014-2019 (K Pcs)
Figure North America Neuroleptic Revenue Growth Rate 2014-2019 (Million USD)
Table North America Neuroleptic Production, Consumption Import and Export (K Pcs)
Figure Europe Neuroleptic Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Neuroleptic Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Neuroleptic Production, Consumption Import and Export (K Pcs)
Figure China Neuroleptic Production Growth Rate 2014-2019 (K Pcs)
Figure China Neuroleptic Revenue Growth Rate 2014-2019 (Million USD)
Table China Neuroleptic Production, Consumption Import and Export (K Pcs)
Figure Japan Neuroleptic Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Neuroleptic Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Neuroleptic Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Neuroleptic Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Neuroleptic Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Neuroleptic Production, Consumption Import and Export (K Pcs)
Figure India Neuroleptic Production Growth Rate 2014-2019 (K Pcs)
Figure India Neuroleptic Revenue Growth Rate 2014-2019 (Million USD)
Table India Neuroleptic Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Neuroleptic Market Share by Application (2014-2019)
Figure Global Value (Consumption) Neuroleptic Market Share by Application (2014-2019)
Table Johnson & Johnso Neuroleptic Production Sites and Area Served
Table Johnson & Johnso Neuroleptic Product Introduction, Application and Specification
Table Johnson & Johnso Neuroleptic Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Johnson & Johnso Neuroleptic Production Growth Rate (2014-2019)
Table Johnson & Johnso Neuroleptic Production Market Share (2014-2019)
Figure Johnson & Johnso Neuroleptic Revenue Market Share (2014-2019)
Table Johnson & Johnso Neuroleptic Main Business and Markets Served
Table Pfizer Neuroleptic Production Sites and Area Served
Table Pfizer Neuroleptic Product Introduction, Application and Specification
Table Pfizer Neuroleptic Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Pfizer Neuroleptic Production Growth Rate (2014-2019)
Table Pfizer Neuroleptic Production Market Share (2014-2019)
Figure Pfizer Neuroleptic Revenue Market Share (2014-2019)
Table Pfizer Neuroleptic Main Business and Markets Served
Table Eli Lilly Neuroleptic Production Sites and Area Served
Table Eli Lilly Neuroleptic Product Introduction, Application and Specification
Table Eli Lilly Neuroleptic Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eli Lilly Neuroleptic Production Growth Rate (2014-2019)
Table Eli Lilly Neuroleptic Production Market Share (2014-2019)
Figure Eli Lilly Neuroleptic Revenue Market Share (2014-2019)
Table Eli Lilly Neuroleptic Main Business and Markets Served
Table Bristol-Myers Squibb Neuroleptic Production Sites and Area Served
Table Bristol-Myers Squibb Neuroleptic Product Introduction, Application and Specification
Table Bristol-Myers Squibb Neuroleptic Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Neuroleptic Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Neuroleptic Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Neuroleptic Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Neuroleptic Main Business and Markets Served
Table GlaxoSmithKline Neuroleptic Production Sites and Area Served
Table GlaxoSmithKline Neuroleptic Product Introduction, Application and Specification
Table GlaxoSmithKline Neuroleptic Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table GlaxoSmithKline Neuroleptic Production Growth Rate (2014-2019)
Table GlaxoSmithKline Neuroleptic Production Market Share (2014-2019)
Figure GlaxoSmithKline Neuroleptic Revenue Market Share (2014-2019)
Table GlaxoSmithKline Neuroleptic Main Business and Markets Served
Figure Global Neuroleptic Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Neuroleptic Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Neuroleptic Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Neuroleptic Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Neuroleptic Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Neuroleptic Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Neuroleptic Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Neuroleptic Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Neuroleptic Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Neuroleptic Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Neuroleptic Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Neuroleptic Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Neuroleptic Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Neuroleptic Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Neuroleptic Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Neuroleptic by Type (2019-2025)
Table Global Consumption (K Pcs) of Neuroleptic by Application (2019-2025)
Table Neuroleptic Distributors List
Table Neuroleptic Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Johnson & Johnso、Pfizer、Eli Lilly、Bristol-Myers Squibb、GlaxoSmithKline、

★調査レポート[世界の神経遮断剤市場 2019年] (コード:DATA909X11953)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の神経遮断剤市場 2019年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆